Research Projects & Grants

Internal

  • Consequences of Withholding Erythropoiesis-Stimulating Agents in Hospitalized Patients, Role: Investigator, LLU Dept. of Pharmacy Practice, (08/2024) Status: Approved
  • Intravenous Iron Treatment for Iron Deficiency in Heart Failure Patients: Assessing Clinical Outcome Improvement, Role: PI, LLU Dept. of Pharmacy Practice, (06/2024) Status: Approved
  • Assessing hypertension management and establishing targets in adult inpatients undergoing hemodialysis, Role: Investigator, LLU Dept. of Pharmacy Practice, (05/2024) Status: Approved
  • Comparison of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate in the Treatment of Acute Hyperkalemia, Role: PI, LLU Dept. of Pharmacy Practice, (09/2023) Status: Approved
  • Acute kidney disease in COVID-19 era: risk factors and prognosis, Role: PI, LLU Dept. of Pharmacy Practice, (08/2022) Status: Approved
  • A retrospective study determining the appropriate dosing of epoetin alfa for initiation and titration in patients with anemia of chronic kidney disease, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved
  • Outpatient Intravenous Furosemide for Patients with Heart Failure, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved